Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Loopia on its acquisition of .SE Direkt
Mandate

Vinge advises Loopia on its acquisition of .SE Direkt

February 11, 2019 M&A

Vinge has advised Loopia on its acquisition of the Swedish Internet Foundation’s (“IIS”) registrar business .SE Direkt.

As of mid-February, .SE Direkt's customers will have Loopia as registrar for their domains. Loopia AB, which is a part of Loopia Group, is one of Sweden's largest and fastest growing web hosting companies with operations in Sweden, Norway, and Serbia. Loopia currently has over 225,000 customers and is a market leader in Sweden within domain names and web hosting. IIS is responsible for the Swedish top-level domain .se and is an independent, business-driven and public organization who works for an internet that contributes positively to people and society.
 
Vinge’s team consisted of partners Christina Kokko (M&A) and Mikael Ståhl (Banking and Finance), and associates Linda Sengul and Martin Cronsioe (M&A), Josefine Larsson (Banking and Finance), Nicklas Thorgerzon (Commercial Agreements) and Klara Secher (IP).
 

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026